| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Pharvaris N.V.'s insiders have reduced their positions by a net 559,502 shares worth roughly $20.4M.
Classified under Biotechnology (Healthcare sector), PHVS's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 650.0K | $22.75M | - | |
| Dir | 115.2K | $4.17M | - | |
| CFO | 113.8K | - | - | |
| Pres | 110.0K | $3.42M | - | |
| Other | 74.0K | $2.83M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | Schikan Johannes Gerardus Christiaan Petrus | Director | Sell10b5-1 | 2,400 | $35.10 | $84,249.84 | -0.7% | -8.1% | - | |
| Jun 26, 2026 | Lu Peng | Chief Medical Officer | Sale+OE10b5-1 | 29,700 | $34.30 | $1,018,831.98 | -31.2% | -3.0% | - | |
| Jun 25, 2026 | Lesage Anne | Chief Early Development | Sale+OE10b5-1 | 4,600 | $35.12 | $161,560.28 | -2.4% | -0.7% | - | |
| Jun 18, 2026 | Lu Peng | Chief Medical Officer | Sale+OE10b5-1 | 300 | $34.00 | $10,200.00 | -0.5% | +14.5% | - | |
| Jun 15, 2026 | Modig Berndt | Chief Executive Officer | Sell10b5-1 | 2,291 | $31.07 | $71,173.04 | -1.7% | +23.2% | - | |
| Jun 4, 2026 | Nijdam Anna | Principal Accounting Officer | Sell | 2,670 | $30.87 | $82,425.04 | -5.5% | +11.2% | - | |
| May 22, 2026 | Nijdam Anna | Principal Accounting Officer | Sale+OE | 7,330 | $30.70 | $225,055.48 | -13.0% | +22.6% | - | |
| May 21, 2026 | Monges Viviane | Director | Sell | 9,667 | $30.29 | $292,853.06 | -63.7% | +18.8% | - | |
| May 21, 2026 | Nassif David W. | CFO / CLO | Sell | 10,000 | $30.31 | $303,076.00 | -7.7% | +18.8% | - | |
| May 20, 2026 | Bjork Elisabeth | Director | Sale+OE10b5-1 | 10,000 | $29.32 | $293,166.00 | -39.7% | +22.6% | - |